Lakefront Biotherapeutics (LKFT) Total Non-Current Liabilities (2013 - 2026)
Lakefront Biotherapeutics (LKFT) reported Total Non-Current Liabilities of $21.82 million for the quarter ended Mar 31, 2026, down 97.5% from $880.44 million a year earlier but up 5.4% from the prior quarter.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Lakefront Biotherapeutics posted Total Non-Current Liabilities of $20.1 million, down 97.9% from the prior year.
- Total Non-Current Liabilities has declined for five consecutive years, with a five-year compound annual growth rate of -90.6% (years ended Dec 2020 to Dec 2025).
- By year, Total Non-Current Liabilities came in at $978.11 million in the year ended Dec 31, 2024 (-19.8%), $1.22 billion in the year ended Dec 31, 2023 (-99.9%), $1.78 trillion in the year ended Dec 31, 2022 (-24.3%) and $2.35 trillion in the year ended Dec 31, 2021 (-14.8%).
- Five-year quarterly Total Non-Current Liabilities spans a low of $20.7 million in the quarter ended Dec 31, 2025 and a high of $2.27 trillion in the quarter ended Dec 31, 2021.
- Year over year, Total Non-Current Liabilities has now declined in each of the last three quarters, with an average decline of 49.0% over the last six quarters.
- Over the past five years, the year-over-year decline in Total Non-Current Liabilities ranged from 2.6% (the quarter ended Jun 30, 2021) to 99.9% (the quarter ended Dec 31, 2023).
- Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at $20.7 million (quarter ended Dec 31, 2025), $816.45 million (quarter ended Sep 30, 2025) and $873.25 million (quarter ended Jun 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Lakefront Biotherapeutics | 1.95 Bn | 1.95 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 21.82 Mn |
| Dec 31, 2025 | 20.70 Mn |
| Sep 30, 2025 | 816.45 Mn |
| Jun 30, 2025 | 873.25 Mn |
| Mar 31, 2025 | 880.44 Mn |
| Dec 31, 2024 | 965.69 Mn |
| Sep 30, 2024 | 1.05 Bn |
| Mar 31, 2024 | 1.18 Bn |
| Dec 31, 2023 | 1.22 Bn |
| Sep 30, 2023 | 1.51 Bn |
| Mar 31, 2023 | 1.66 Bn |
| Dec 31, 2022 | 1,719.92 Bn |
| Mar 31, 2022 | 2.12 Bn |
| Dec 31, 2021 | 2,268.87 Bn |
| Jun 30, 2021 | 2.64 Bn |
| Dec 31, 2020 | 2,875.92 Bn |
| Jun 30, 2020 | 2.71 Bn |
| Mar 31, 2020 | 2.79 Bn |
| Dec 31, 2019 | 2.90 Bn |
| Sep 30, 2019 | 2.99 Bn |
API Access
Lakefront Biotherapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();